All In MedTech

FDA Clearance Tracker · P000043-S016

THERMATRX OFFICE THERMO THERAPY

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 13, 2006 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 13, 2006

Approved

Time to decision

21 days

Received Sep 22, 2006. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P000043-S016
Device name
THERMATRX OFFICE THERMO THERAPY
Applicant location
Marlboro, MA
Received
Sep 22, 2006
Decided
Oct 13, 2006
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P000043

Device type

Device class
Class III

Every decision under product code MEQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT MRI MANUFACTURING AND RESEARCH, INC., TUCSON, ARIZONA TO CONDUCT PACKAGING AND LABELING FOR THE RX-200 APPLICATOR (CATHETER).

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.